Antibodies to the brain-specific protein S-100 (Anticorpora ad proteino S-100 cerebrospecifico)

Pharmacodynamics Pharmacokinetics Indications Carefully Contraindications Dosing and Administration Side effects
Read on
Clinical and pharmacological group: & nbsp

Anxiolytics

Homeopathic Remedies

Nootropics

Included in the formulation
  • Proproten-100
    drops inwards 
    NPF Materia Medica Holding, OOO     Russia
  • Proproten-100
    pills inwards 
    NPF Materia Medica Holding, OOO     Russia
  • Tenoten
    pills inwards 
    NPF Materia Medica Holding, OOO     Russia
  • Tenoten for children
    pills inwards d / children 
    NPF Materia Medica Holding, OOO     Russia
    • Included in the list (Order of the Government of the Russian Federation No. 2782-r of 30.12.2014):

    ONLS

    АТХ:

    N.06.A.X   Other antidepressants

    Pharmacodynamics:

    Due to the activation of the inhibitory action of gamma-aminobutyric acid (GABA), the excitability of neurons of the central nervous system is depressed. Inhibits the process of lipid peroxidation, normalizes the integrative activity of the brain, providing an anxiolytic and antidepressant effect.

    The drug has no sedative effect.

    Pharmacokinetics:

    The absence of highly effective methods for studying ultra-small doses of antibodies does not allow studying the pharmacokinetics of the drug.

    Indications:

    Used for neurotic and neurosis-like conditions, stress disorders and moderate organic lesions of the central nervous system, manifested by emotional lability, memory impairment, autonomic disorders.

    ICD-10

    V.F60-F69.F69   Disorder of personality and behavior in adulthood, unspecified

    V.F60-F69.F60.9   Personality disorder, unspecified

    V.F60-F69   Disorders of personality and behavior in adulthood

    Contraindications:

    Individual intolerance.

    Carefully:Be used with caution in patients with lactase intolerance, as part of the drug is present lactose.
    Pregnancy and lactation:

    Pregnancy and lactation: recommendations for Food and Drug Administration (US Food and Drug Administration) - category is not defined. There is no evidence of ingestion into breast milk. When prescribing a drug, the relationship between risk and benefit is taken into account.

    Dosing and Administration:

    1-2 tablets under the tongue until complete resorption: 2-4 times a day. The course of treatment is 1-3 months, extended by clinical indications to 6 months. The repeated course is conducted after 1-2 months. In the liquid form, the drug is applied 10 drops (two tablets).

    The highest daily dose: 8-10 tablets.

    The highest single dose: 2 tablets (10 drops).

    Side effects:

    Hyperhidrosis, heartburn, flatulence, diarrhea.

    Allergic reactions.

    Overdose:

    Cases of overdose are not described.

    Interaction:

    Disintegrating tablets and drops are used outside of food intake.

    Special instructions:

    The drug has a slight tonic effect - the last reception is recommended 2 hours before bedtime.

    Instructions
    Up